The physics, biophysics and technology of photodynamic therapy

Physics in Medicine and Biology

Volumn 53, Issue 9, 2008, Pages

  Wilson, Brian C ^a,b   Patterson, Michael S ^c,d  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c JURAVINSKI CANCER CENTRE   (Canada)

^d MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOPHYSICS; DISEASES; DRUG PRODUCTS; ONCOLOGY; OPTIMIZATION; PHOTOSENSITIZERS; TUMORS;

DOSE RATES; MACULAR DEGENERATION;

PHOTODYNAMIC THERAPY;

NANOPARTICLE; OXYGEN; PHOTOSENSITIZING AGENT; VERTEPORFIN;

ABSORPTION; BIOPHYSICS; CALCULATION; CANCER THERAPY; DOSIMETRY; HUMAN; INFECTION; LIGHT; LIGHT EMITTING DIODE; LIGHT SCATTERING; MEASUREMENT; MOLECULAR DYNAMICS; OPTICS; PEER REVIEW; PHOTOCHEMISTRY; PHOTODYNAMIC THERAPY; PHYSICS; PRIORITY JOURNAL; PUVA; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; SENSITIVITY ANALYSIS; SKIN DISEASE; TECHNOLOGY; TREATMENT INDICATION;

BIOPHYSICS; EQUIPMENT DESIGN; FEMALE; HUMANS; LIGHT; MACULAR DEGENERATION; MALE; MODELS, STATISTICAL; NANOPARTICLES; NEOPLASMS; PHOTOCHEMOTHERAPY; PHOTONS; PHOTOSENSITIZING AGENTS; PHYSICS; RADIOMETRY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED;

EID: 42449109537     PISSN: 00319155     EISSN: 13616560     Source Type: Journal    
DOI: 10.1088/0031-9155/53/9/R01     Document Type: Review

References (183)

1. Aalders M C G, Triesscheijn M, Ruevekamp M, de Bruin M, Baas P, Faber D J and Stewart F A 2006 Doppler optical coherence tomography to monitor the effect of photodynamic therapy on tissue morphology and perfusion J. Biomed. Opt. 11 044011
2. Alexandrakis G, Farrell T J and Patterson M S 1998 Accuracy of the diffusion approximation in determining the optical properties of a two-layer turbid medium Appl. Opt. 37 7401-9
3. Arridge S R, Hebden J C, Schwinger M, Schmidt F E W, Fry M E, Hillman E M C, Dehghani H and Delpy D T 2000 A method for three-dimensional time-resolved optical tomography Int. J. Imaging Syst. Tech. 11 2-11
4. Arridge S R, Schweiger M, Hiraoka M and Delpy D T 1993 A finite-element approach for modeling photon transport in tissue Med. Phys. 20 299-309
5. Barr H, Tralau C J, Boulos P B, MacRobert A J, Tilly R and Bown S G 1987 The contrasting mechanisms of colonic collagen damage between photodynamic therapy and thermal injury Photochem. Photobiol. 46 795-800
6. Beek J F, Blokland P, Posthumus P, Aalders M, Pickering J W, Sterenborg H J C M and vanGemert M J C 1997 In vitro double-integrating-sphere optical properties of tissues between 630 and 1064 nm Phys. Med. Biol. 42 2255-61
7. Ben Hur E 1998 Inactivation of pathogens in blood and blood products Med. Health R. I. 81 396-9
8. Berard V, Lecomte R and Van Lier J E 2006 Positron emission tomography imaging of tumor response after photodynamic therapy J. Environ. Pathol. Toxicol. Oncol. 25 239-49
9. Betz C S, Jager H R, Brookes J A, Richards R, Leunig A and Hopper C 2007 Interstitial photodynamic therapy for a symptom-targeted treatment of complex vascular malformations in the head and neck region Lasers Surg. Med. 39 571-82
10. Biel M 2006 Advances in photodynamic therapy for the treatment of head and neck cancers Lasers Surg. Med. 38 349-55
11. Bisland S K, Lilge L, Lin A, Rusnov R and Wilson B C 2004 Metronomic photodynamic therapy as a new paradigm for photodynamic therapy: rationale and preclinical evaluation of technical feasibility for treating malignant brain tumors Photochem. Photobiol. 80 22-30
12. Boere I A, Robinson D J, de Bruijn H S, Kluin J, Tilanus H W, Sterenborg H J C M and de Bruin R W F 2006 Protoporphyrin IX fluorescence photobleaching and the response of rat Barrett's esophagus following 5-aminolevulinic acid photodynamic therapy Photochem. Photobiol. 82 1638-44
13. Brancaleon L and Moseley H 2002 Laser and non-laser light sources for photodynamic therapy Lasers Med. Sci. 17 173-86
14. Bressler N M et al 2005 Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: four-year results of an open-label extension of 2 randomized clinical trials: TAP Report No. 7 Arch. Ophthalmol. 123 1283-5
15. Brown S B, Brown E A and Walker I 2004 The present and future role of photodynamic therapy in cancer treatment Lancet Oncol. 5 497-508
16. Buerk D G 2004 Measuring tissue PO2 with microelectrodes Methods Enzymol. 381 665-90
17. Burch S, Bogaards A, Siewerdsen J, Moseley D, Yee A, Finkelstein J, Weersink R, Wilson B C and Bisland S K 2005 Photodynamic therapy for the treatment of metastatic lesions in bone: studies in rat and porcine models J. Biomed. Opt. 10 034011
18. Busch T M 2006 Local physiological changes during photodynamic therapy Lasers Surg. Med. 38 494-9
19. Cengel K A, Glatstein E and Hahn S M 2007 Intraperitoneal photodynamic therapy Cancer Treat. Res. 134 493-514
20. Chabrier-Rosello Y, Foster T H, Perez-Nazario N, Mitra S and Haidaris C G 2005 Sensitivity of Candida albicans germ tubes and biofilms to Photofrin-mediated phototoxicity Antimicrob. Agents Chemother. 49 4288-95
21. Chen Q, Chen H and Hetzel F W 1996 Tumor oxygenation changes post-photodynamic therapy Photochem. Photobiol. 63 128-31
22. Chen Q, Huang Z, Chen H, Shapiro H, Beckers J and Hetzel F W 2002a Improvement of tumor response by manipulation of tumor oxygenation during photodynamic therapy Photochem. Photobiol. 76 197-203
23. Chen J, Keltner L, Christophersen J, Zheng F, Krouse M, Singhal A and Wang S S 2002b New technology for deep light distribution in tissue for phototherapy Cancer J. 8 154-63
24. Chen Z P, Milner T E, Wang X J, Srinivas S and Nelson J S 1998 Optical Doppler tomography: imaging in vivo blood flow dynamics following pharmacological intervention and photodynamic therapy Photochem. Photobiol. 67 56-60
25. Cheong W F, Prahl S A and Welch A J 1990 A review of the optical properties of biological tissues IEEE J. Quantum Elect. 26 2166-85
26. Chou T M, Woodburn K W, Cheong W F, Lacy S A, Sudhir K, Adelman D C and Wahr D 2002 Photodynamic therapy: applications in atherosclerotic vascular disease with motexafin lutetium Catheter. Cardiovasc. Interv. 57 387-94
27. Conover D L, Fenton B M, Foster T H and Hull E L 2000 An evaluation of near infrared spectroscopy and cryospectrophotometry estimates of haemoglobin oxygen saturation in a rodent mammary tumour model Phys. Med. Biol. 45 2685-700
28. Coutier S, Bezdetnaya L N, Foster T H, Parache R M and Guillemin F 2002 Effect of irradiation fluence rate on the efficacy of photodynamic therapy and tumor oxygenation in meta-tetra(hydroxyphenyl)chlorin (mTHPC)-sensitized HT29 xenografts in nude mice Radiat. Res. 158 339-45
29. Czarnota G J, Kolios M C, Abraham J, Portnoy M, Ottensmeyer F P, Hunt J W and Sherar M D 1999 Ultrasound imaging of apoptosis: high-resolution non-invasive monitoring of programmed cell death in vitro, in situ and in vivo Br. J. Cancer 81 520-7
30. Davies N 2006 Development of metronomic photodynamic therapy as a treatment for newly initiated brain tumors MSc Thesis University of Toronto
31. de Haas E R M, de Vijlder H C, Sterenborg H J C M, Neumann H A M and Robinson D J 2007 Fractionated aminolevulinic acid-photodynamic therapy provides additional evidence for the use of PDT for non-melanoma skin cancer J. Eur. Acad. Dermatol. Venereol. doi:10.1111/j.1468-3083.200702445x
32. Delpy D T, Cope M, Vanderzee P, Arridge S, Wray S and Wyatt J 1988 Estimation of optical pathlength through tissue from direct time of flight measurement Phys. Med. Biol. 33 1433-42
33. Demidova T N and Hamblin M R 2004 Photodynamic therapy targeted to pathogens Int. J. Immunopathol. Pharmacol. 17 245-54
34. Diamond K R, Farrell T J and Patterson M S 2003a Measurement of fluorophore concentrations and fluorescence quantum yield in tissue-simulating phantoms using three diffusion models of steady-state spatially resolved fluorescence Phys. Med. Biol. 48 4135-49
35. Diamond K R, Patterson M S and Farrell T J 2003b Quantification of fluorophore concentration in tissue-simulating media by fluorescence measurements with a single optical fiber Appl. Opt. 42 2436-42
36. Dougherty T J, Kaufman J E, Goldfarb A, Weishaupt K R, Boyle D and Mittleman A 1978 Photoradiation therapy for treatment of malignant tumors Cancer Res. 38 2628-35
37. Dougherty T J, Lawrence G, Kaufman J H, Boyle D, Weishaupt K R and Goldfarb A 1979 Photoradiation in the treatment of recurrent breast carcinoma J. Natl Cancer Inst. 62 231-7
38. Du K L et al 2006 Preliminary results of interstitial motexafin lutetium-mediated PDT for prostate cancer Lasers Surg. Med. 38 427-34
39. Dysart J S and Patterson M S 2005 Characterization of Photofrin photobleaching for singlet oxygen dose estimation during photodynamic therapy of MLL cells in vitro Phys. Med. Biol. 50 2597-616
40. Dysart J S and Patterson M S 2006 Photobleaching kinetics, photoproduct formation, and dose estimation during ALA induced PpIX PDT of MLL cells under well oxygenated and hypoxic conditions Photochem. Photobiol. Sci. 5 73-81
41. Dysart J S, Singh G and Patterson M S 2005 Calculation of singlet oxygen dose from photosensitizer fluorescence and photobleaching during mTHPC photodynamic therapy of MLL cells Photochem. Photobiol. 81 196-205
42. Eggener S E et al 2007 Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities J. Urol. 178 2260-7
43. Farrell T J, Patterson M S, Hayward J E, Wilson B C and Beck E R 1994 A CCD and neural network based instrument for the non-invasive determination of tissue optical properties in-vivo SPIE Proc. 2135 117-28
44. Farrell T J, Wilson B C, Patterson M S and Olivo M C 1998 Comparison of the in vivo photodynamic threshold dose for Photofrin, mono- and tetrasulfonated aluminum phthalocyanine using a rat liver model Photochem. Photobiol. 68 394-9
45. Ferrari M 2005 Cancer nanotechnology: opportunities and challenges Nat. Rev. Cancer 5 161-71
46. Fien S M and Oseroff A R 2007 Photodynamic therapy for non-melanoma skin cancer J. Natl Compr. Canc. Netw. 5 531-40
47. Finlay J C and Foster T H 2004 Hemoglobin oxygen saturations in phantoms and in vivo from measurements of steady-state diffuse reflectance at a single, short source-detector separation Med. Phys. 31 1949-59
48. Finlay J C, Mitra S, Patterson M S and Foster T H 2004 Photobleaching kinetics of Photofrin in vivo and in multicell tumour spheroids indicate two simultaneous bleaching mechanisms Phys. Med. Biol. 49 4837-60
49. Firbank M, Hiraoka M, Essenpreis M and Delpy D T 1993 Measurement of the optical properties of the skull in the wavelength range 650-950 nm Phys. Med. Biol. 38 503-10
50. Fischer H C, Liu L C, Pang K S and Chan W C W 2006 Pharmacokinetics of nanoscale quantum dots: in vivo distribution, sequestration, and clearance in the rat Adv. Funct. Mater. 16 1299-305
51. Flock S T, Wilson B C and Patterson M S 1987 Total attenuation coefficients and scattering phase functions of tissues and phantom materials at 633 nm Med. Phys. 14 835-41
52. Foote C S 1991 Definition of Type-I and Type-II photosensitized oxidation Photochem. Photobiol. 54 659
53. Forrer M, Glanzmann T, Braichotte D, Wagnieres G, van den Bergh H, Savary J F and Monnier P 1995 In vivo measurement of fluorescence bleaching of meso-tetrahydroxyphenyl chlorin (mTHPC) in the esophagus and oral cavity SPIE Proc. 2627 33-9
54. Foster T H and Gao L 1992 Dosimetry in photodynamic therapy-oxygen and the critical importance of capillary density Radiat. Res. 130 379-83
55. Foster T H, Murant R S, Bryant R G, Knox R S, Gibson S L and Hilf R 1991 Oxygen consumption and diffusion effects in photodynamic therapy Radiat. Res. 126 296-303
56. Funke B, Jungel A, Schastak S, Wiedemeyer K, Emmrich F and Sack U 2006 Transdermal photodynamic therapy-a treatment option for rheumatic destruction of small joints? Lasers Surg. Med. 38 866-74
57. Gersing E, Kelleher D K and Vaupel P 2003 Tumour tissue monitoring during photodynamic and hyperthermic treatment using bioimpedance spectroscopy Physiol. Meas. 24 625-37
58. Ghosh N, Mohanty S K, Majumder S K and Gupta P K 2001 Measurement of optical transport properties of normal and malignant human breast tissue Appl. Opt. 40 176-84
59. Gibson A P, Hebden J C and Arridge S R 2005 Recent advances in diffuse optical imaging Phys. Med. Biol. 50 R1-43
60. Gold M H 2007 Acne and PDT: new techniques with lasers and light sources Lasers Med. Sci. 22 67-72
61. Gomer C J, Luna M, Ferrario A, Wong S, Fisher A M and Rucker N 1996 Cellular targets and molecular responses associated with photodynamic therapy J. Clin. Laser Med. Surg. 14 315-21
62. Gorman A A and Rodgers M A J 1992 Current perspectives of singlet oxygen detection in biological environments J. Photochem. Photobiol. B: Biol. 14 159-76
63. Gross S, Gilead A, Scherz A, Neeman M and Salomon Y 2003 Monitoring photodynamic therapy of solid tumors online by BOLD-contrast MRI Nat. Med. 9 1327-31
64. Hahn S M, Putt M E, Metz J, Shin D B, Rickter E, Menon C, Smith D, Glatstein E, Fraker D L and Busch T M 2006 Photofrin uptake in the tumor and normal tissues of patients receiving intraperitoneal photodynamic therapy Clin. Cancer Res. 12 5464-70
65. Haider M A et al 2007 Prostate gland: MR imaging appearance after vascular targeted photodynamic therapy with palladium-bacteriopheophorbide Radiology 244 196-204
66. Henderson B W, Busch T M and Snyder J W 2006 Fluence rate as a modulator of PDT mechanisms Lasers Surg. Med. 38 489-93
67. Henderson B W and Dougherty T J 1992 How does photodynamic therapy work Photochem. Photobiol. 55 145-57
68. Henderson B W, Gollnick S O, Snyder J W, Busch T M, Kousis P C, Cheney R T and Morgan J 2004 Choice of oxygen-conserving treatment regimen determines the inflammatory response and outcome of photodynamic therapy of tumors Cancer Res. 64 2120-6
69. Henderson B W et al 2000 Photofrin photodynamic therapy can significantly deplete or preserve oxygenation in human basal cell carcinomas during treatment, depending on fluence rate Cancer Res. 60 525-9
70. Hetzel F W, Brahmavar S M, Chen Q, Jacques S L, Patterson M S, Wilson B C and Zhu T C 2005 Photodynamic therapy dosimetry (Madison, WI: Medical Physics Publishing) AAPM Report #88
71. Hirano T, Kohno E and Nishiwaki M 2002 Detection of near infrared emission from singlet oxygen in PDT with an experimental tumor bearing mouse J. Japan. Soc. Laser Surg. Med. 22 99-108
72. Hirschberg H, Madsen S, Lote K, Pham T and Tromberg B 1999 An indwelling brachytherapy balloon catheter: potential use as an intracranial light applicator for photodynamic therapy J. Neurooncol. 44 15-21
73. Hopper C, Kubler A, Lewis H, Tan I B and Putnam G 2004 mTHPC-mediated photodynamic therapy for early oral squamous cell carcinoma Int. J. Cancer 111 138-46
74. Huang Z, Chen Q, Luck D, Beckers J, Wilson B C, Trncic N, Larue S M, Blanc D and Hetzel F W 2005 Studies of a vascular-acting photosensitizer, Pd-bacteriopheophorbide (TOOKAD), in normal canine prostate and spontaneous canine prostate cancer Lasers Surg. Med. 36 390-7
75. Jacques S L 1998 Light distributions from point, line and plane sources for photochemical reactions and fluorescence in turbid biological tissues Photochem. Photobiol. 67 23-32
76. Jarvi M T, Niedre M J, Patterson M S and Wilson B C 2006 Singlet oxygen luminescence dosimetry (SOLD) for photodynamic therapy: current status, challenges and future prospects Photochem. Photobiol. 82 1198-210
77. Jeeves W P, Wilson B C, Firnau G and Brown K 1985 Studies of HPD and radiolabeled HPD in vivo and in vitro Adv. Exp. Med. Biol. 193 51-67
78. Johansson A, Axelsson J and Andersson-Engels S 2007 Realtime light dosimetry software tools for interstitial photodynamic therapy of the human prostate Med. Phys. 34 4309-21
79. Jori G and Brown S B 2004 Photosensitized inactivation of microorganisms Photochem. Photobiol. Sci. 3 403-5
80. Juan C, Stefflova K, Niedre M J, Wilson B C, Chance B, Glickson J D and Gang Z 2004 Protease-triggered photosensitizing beacon based on singlet oxygen quenching and activation J. Am. Chem. Soc. 126 11450-1
81. Key H, Davies E R, Jackson P C and Wells P N T 1991 Optical attenuation characteristics of breast tissues at visible and near-infrared wavelengths Phys. Med. Biol. 36 579-90
82. Khurana M, Collins H A, Karotki A, Anderson H L, Cramb D T and Wilson B C 2007 Quantitative in vitro demonstration of two-photon photodynamic therapy using Photofrin ® and Visudyne® Photochem. Photobiol. 83 1441-8
83. Kovalev D and Fujii M 2005 Silicon nanocrystals: photosensitizers for oxygen molecules Adv. Mater. 17 2531-44
84. Lilge L, Portnoy M and Wilson B C 2000 Apoptosis induced in vivo by photodynamic therapy in normal brain and intracranial tumour tissue Br. J. Cancer 83 1110-17
85. Luna M C, Wong S and Gomer C J 1994 Photodynamic therapy mediated induction of early response genes Cancer Res. 54 1374-80
86. Luo Y and Shoichet M S 2004 A photolabile hydrogel for guided three-dimensional cell growth and migration Nat. Mater. 3 249-53
87. Maisch T 2007 Anti-microbial photodynamic therapy: useful in the future? Lasers Med. Sci. 22 83-91
88. Marijnissen J P A and Star W M 1996 Calibration of isotropic light dosimetry probes based on scattering bulbs in clear media Phys. Med. Biol. 41 1191-208
89. Marijnissen J P A and Star W M 2002 Performance of isotropic light dosimetry probes based on scattering bulbs in turbid media Phys. Med. Biol. 47 2049-58
90. Markel V A 2004 Modified spherical harmonics method for solving the radiative transport equation Waves Random Media 14 L13-9
91. Mazor O, Brandis A, Plaks V, Neumark E, Rosenbach-Belkin V, Salomon Y and Scherz A 2005 WST11: a novel water-soluble bacteriochlorophyll derivative; cellular uptake, pharmacokinetics, biodistribution and vascular-targeted photodynamic activity using melanoma tumors as a model Photochem. Photobiol. 81 342-51
92. Mennel S, Barbazetto I, Meyer C H, Peter S and Stur M 2007 Ocular photodynamic therapy-standard applications and new indications (Part 1) Ophthalmologica 221 216-26
93. Mir Y, Houde D and Van Lier J E 2006 Two-photon absorption of copper tetrasulfophthalocyanine induces phototoxicity towards Jurkat cells in vitro Photochem. Photobiol. Sci. 5 1024-30
94. Mir Y, Houde D and Van Lier J E 2008 Photodynamic inhibition of acetylcholinesterase after two-photon excitation of copper tetrasulfophthalocyanine Lasers Med. Sci. 23 19-25
95. Mitra S, Goren E M, Frelinger J G and Foster T H 2003 Activation of heat shock protein 70 promoter with meso-tetrahydroxyphenyl chlorin photodynamic therapy reported by green fluorescent protein in vitro and in vivo Photochem. Photobiol. 78 615-22
96. Miyagi K, Sampson R W, Sieber-Blum M and Sieber F 2003 Crystal violet combined with merocyanine 540 for the ex vivo purging of hematopoietic stem cell grafts J. Photochem. Photobiol. 70 133-44
97. Moan J and Peng Q 2003 An outline of the hundred-year history of PDT Anticancer Res. 23 3591-600
98. Moan J and Sommer S 1985 Oxygen dependence of the photosensitizing effect of hematoporphyrin derivative in NHIK 3025 cells Cancer Res. 45 1608-10
99. Molckovsky A and Wilson B C 2001 Monitoring of cell and tissue responses to photodynamic therapy by electrical impedance spectroscopy Phys. Med. Biol. 46 983-1002
100. Moore R B, Chapman J D, Mokrzanowski A D, Arnfield M R, Mcphee M S and Mcewan A J 1992 Noninvasive monitoring of photodynamic therapy with Tc-99 HMPAO scintigraphy Br. J. Cancer 65 491-7
101. Moriyama E H, Bisland S K, Lilge L and Wilson B C 2004 Bioluminescence imaging of the response of rat gliosarcoma to ALA-PpIX-mediated photodynamic therapy Photochem. Photobiol. 80 242-9
102. Moseley H, Allen J W, Ibbotson S, Lesar A, McNeill A, Camacho-Lopez M A, Samuel I D, Sibbett W and Ferguson J 2006 Ambulatory photodynamic therapy: a new concept in delivering photodynamic therapy Br. J. Dermatol. 154 747-50
103. Nestor M S et al 2006 The use of photodynamic therapy in dermatology: results of a consensus conference J. Drugs Dermatol. 5 140-54
104. Niedre M, Patterson M S and Wilson B C 2002 Direct near-infrared luminescence detection of singlet oxygen generated by photodynamic therapy in cells in vitro and tissues in vivo Photochem. Photobiol. 75 382-91
105. Niedre M J, Secord A J, Patterson M S and Wilson B C 2003 In vitro tests of the validity of singlet oxygen luminescence measurements as a dose metric in photodynamic therapy Cancer Res. 63 7986-94
106. Niedre M J, Yu C S, Patterson M S and Wilson B C 2005 Singlet oxygen luminescence as an in vivo photodynamic therapy dose metric: validation in normal mouse skin with topical amino-levulinic acid Br. J. Cancer 92 298-304
107. Nseyo U O, DeHaven J, Dougherty T J, Potter W R, Merrill D L, Lundahl S L and Lamm D L 1998 Photodynamic therapy (PDT) in the treatment of patients with resistant superficial bladder cancer: a long-term experience J. Clin. Laser Med. Surg. 16 61-8
108. Nyst H J, van Veen R L P, Tan I B, Peters R, Spaniol S, Robinson D J, Stewart F A, Levendag P C and Sterenborg H J 2007 Performance of a dedicated light delivery and dosimetry device for photodynamic therapy of nasopharyngeal carcinoma: phantom and volunteer experiments Lasers Surg. Med. 39 647-53
109. Ohlerth S, Laluhova D, Buchholz J, Roos M, Walt H and Kaser-Hotz B 2006 Changes in vascularity and blood volume as a result of photodynamic therapy can be assessed with power Doppler ultrasonography Lasers Surg. Med. 38 229-34
110. Oleinick N L and Evans H H 1998 The photobiology of photodynamic therapy: cellular targets and mechanisms Radiat. Res. 150 S146-56
111. Overholt B F et al 2007 Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia Gastrointest. Endosc. 66 460-8
112. Pandey S K et al 2005 Multimodality agents for tumor imaging (PET, fluorescence) and photodynamic therapy. A possible see and treat approach J. Med. Chem. 48 6286-95
113. Panjehpour M, Overholt B F, Denovo R C, Petersen M G and Sneed R E 1993 Comparative study between pulsed and continuous-wave lasers for Photofrin® photodynamic therapy Lasers Surg. Med. 13 296-304
114. Papkovsky D B 2004 Methods in optical oxygen sensing: Protocols and critical analyses Methods Enzymol. 381 715-35
115. Patterson M S, Madsen S J and Wilson B C 1990a Experimental tests of the feasibility of singlet oxygen luminescence monitoring in vivo during photodynamic therapy J. Photochem. Photobiol. 5 69-84
116. Patterson M S, Wilson B C and Graff R 1990b In vivo tests of the concept of photodynamic threshold dose in normal rat liver photosensitized by aluminum chlorosulphonated phthalocyanine Photochem. Photobiol. 51 343-9
117. Patterson M S, Wilson B C and Wyman D R 1990c The propagation of optical radiation in tissue: I. Models of radiation transport and their application Lasers Med. Sci. 6 155-68
118. Peters V G, Wyman D R, Patterson M S and Frank G L 1990 Optical properties of normal and diseased human breast tissues in the visible and near infrared Phys. Med. Biol. 35 1317-34
119. Pickering J W, Prahl S A, Vanwieringen N, Beek J F, Sterenborg H J C M and vanGemert M J C 1993 Double-integrating-sphere system for measuring the optical properties of tissue Appl. Opt. 32 399-410
120. Pogue B W and Burke G 1998 Fiber-optic bundle design for quantitative fluorescence measurement from tissue Appl. Opt. 37 7429-36
121. Pogue B W, Geimer S, McBride T O, Jiang S D, Osterberg U L and Paulsen K D 2001 Three-dimensional simulation of near-infrared diffusion in tissue: boundary condition and geometry analysis for finite-element image reconstruction Appl. Opt. 40 588-600
122. Popp A K, Valentine M T, Kaplan P D and Weitz D A 2003 Microscopic origin of light scattering in tissue Appl. Opt. 42 2871-80
123. Redmond R W and Gamlin J N 1999 A compilation of singlet oxygen yields from biologically relevant molecules Photochem. Photobiol. 70 391-475
124. Rendon A, Weersink R and Lilge L 2006 Towards conformal light delivery using tailored cylindrical diffusers: attainable light dose distributions Phys. Med. Biol. 51 5967-75
125. Robinson D J, de Bruijn H S, van der Veen N, Stringer M R, Brown S B and Star W M 1998 Fluorescence photobleaching of ALA-induced protoporphyrin IX during photodynamic therapy of normal hairless mouse skin: the effect of light dose and irradiance and the resulting biological effect Photochem. Photobiol. 67 140-9
126. Rodgers M A J 1988 On the problems involved in detecting luminescence from singlet oxygen in biological specimens J. Photochem. Photobiol. B: Biol. 1 371-3
127. Rogers D W O 2006 Fifty years of Monte Carlo simulations for medical physics Phys. Med. Biol. 51 R287-301
128. Roth Y, Tichler T, Kostenich G, Ruiz-Cabello J, Maier S E, Cohen J S, Orenstein A and Mardor Y 2004 High-b-value diffusion-weighted MR imaging for pretreatment prediction and early monitoring of tumor response to therapy in mice Radiology 232 685-92
129. Samia A C, Dayal S and Burda C 2006 Quantum dot-based energy transfer: perspectives and potential for applications in photodynamic therapy Photochem. Photobiol. 82 617-25
130. Samkoe K S, Clancy A A, Karotki A, Wilson B C and Cramb D T 2007 Complete blood vessel occlusion in the chick chorioallantoic membrane using two-photon excitation photodynamic therapy: implications for treatment of wet age-related macular degeneration J. Biomed. Opt. 12 034025
131. Samuel I 2007 Light fantastic Materials World 28-30 August
132. Schmitt J M and Kumar G 1998 Optical scattering properties of soft tissue: a discrete particle model Appl. Opt. 37 2788-97
133. See K L, Forbes I J and Betts W H 1984 Oxygen dependency of photocytotoxicity with hematoporphyrin derivative Photochem. Photobiol. 39 631-4
134. Sheng C, Pogue B W, Wang E, Hutchins J E and Hoopes P J 2004 Assessment of photosensitizer dosimetry and tissue damage assay for photodynamic therapy in advanced-stage tumors Photochem. Photobiol. 79 520-5
135. Sheppard C J R 2007 Fractal model of light scattering in biological tissue and cells Opt. Lett. 32 142-4
136. Simpson C R, Kohl M, Essenpreis M and Cope M 1998 Near-infrared optical properties of ex vivo human skin and subcutaneous tissues measured using the Monte Carlo inversion technique Phys. Med. Biol. 43 2465-78
137. Smith G, McGimpsey W G, Lynch M C, Kochevar I E and Redmond R W 1994 An efficient oxygen independent 2-photon photosensitization mechanism Photochem. Photobiol. 59 135-9
138. Smits T, Kleinpenning M M, van Erp P E, van de Kerkhof P C and Gerritsen M J 2006 A placebo-controlled randomized study on the clinical effectiveness, immunohistochemical changes and protoporphyrin IX accumulation in fractionated 5-aminolevulinic acid-photodynamic theraphy in patients with psoriasis Br. J. Dermatol. 155 429-36
139. Spangler J W, Starkey J R, Rebane A, Meng F, Gong A and Drobizhev I 2006 Synthesis, characterization, and preclinical studies of two-photon-activated targeted PDT therapeutic triads SPIE Proc. 6139 61390X
140. Standish B A, Jin X, Smolen J, Mariampillai A, Munce N R, Wilson B C, Vitkin I A and Yang V X 2007a Interstitial Doppler optical coherence tomography monitors microvascular changes during photodynamic therapy in a Dunning prostate model under varying treatment conditions J. Biomed. Opt. 12 034022
141. Standish B A, Yang V X, Munce N R, Wong Kee, Song L M, Gardiner G, Lin A, Mao Y I, Vitkin A, Marcon N E and Wilson B C 2007b Doppler optical coherence tomography monitoring of microvascular tissue response during photodynamic therapy in an animal model of Barrett's esophagus Gastrointest. Endosc. 66 326-33
142. Star W M, Marijnissen H P A, Jansen H, Keijzer M and vanGemert M J C 1987 Light dosimetry for photodynamic therapy by whole bladder wall irradiation Photochem. Photobiol. 46 619-24
143. Stefflova K, Chen J and Zheng G 2007 Killer beacons for combined cancer imaging and therapy Curr. Med. Chem. 14 2110-25
144. Sterenborg H J C M and vanGemert M J C 1996 Photodynamic therapy with pulsed light sources: a theoretical analysis Phys. Med. Biol. 41 835-49
145. Stylli S S and Kaye A H 2006 Photodynamic therapy of cerebral glioma-a review. Part II. Clinical studies J. Clin. Neurosci. 13 709-17
146. Synytsya A, Kral V, Matejka P, Pouckova P, Volka K and Sessler J L 2004 Biodistribution assessment of a lutetium(III) texaphyrin analogue in tumor-bearing mice using NIR Fourier-transform Raman spectroscopy Photochem. Photobiol. 79 453-60
147. Tang H M, Hamblin M R and Yow C M 2007 A comparative in vitro photoinactivation study of clinical isolates of multidrug-resistant pathogens J. Infect. Chemother. 13 87-91
148. Thompson M S, Johansson A, Johansson T, Andersson-Engels S, Svanberg S, Bendsoe N and Svanberg K 2005 Clinical system for interstitial photodynamic therapy with combined on-line dosimetry measurements Appl. Opt. 44 4023-31
149. Trachtenberg J et al 2007 Vascular targeted photodynamic therapy with palladium-bacteriopheophorbide photosensitizer for recurrent prostate cancer following definitive radiation therapy: assessment of safety and treatment response J. Urol. 178 1974-9
150. Tromberg B J, Orenstein A, Kimel S, Barker S J, Hyatt J, Nelson J S and Berns M W 1990 In vivo tumor oxygen-tension measurements for the evaluation of the efficiency of photodynamic therapy Photochem. Photobiol. 52 375-85
151. Tschen E H, Wong D S, Pariser D M, Dunlap F E, Houlihan A and Ferdon M B 2006 Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up Br. J. Dermatol. 155 1262-9
152. Usuda J et al 2006 Photodynamic therapy (PDT) for lung cancers J. Thorac. Oncol. 1 489-93
153. Van Dyk J 1999 Radiation oncology overview The Modern Technology of Radiation Oncology ed J van Dyk (Madison, WI: Medical Physics Publishing) pp 1-17
154. van Staveren H J, Marijnissen H P A, Aalders M C G and Star W M 1995 Construction, quality assurance and calibration of spherical isotropic fibre optic light diffusers Lasers Med. Sci. 10 137-47
155. van Staveren H J, Moes C J M, Vanmarle J, Prahl S A and vanGemert M J C 1991 Light scattering in Intralipid-10-percent in the wavelength range of 400-1100 nm Appl. Opt. 30 4507-14
156. van Veen R L P, Robinson D J, Siersema P D and Sterenborg H J C M 2006 The importance of in situ dosimetry during photodynamic therapy of Barrett's esophagus Gastrointest. Endosc. 64 786-8
157. Veenhuizen R B and Stewart F A 1995 The importance of fluence rate in photodynamic therapy-is there a parallel with ionizing-radiation dose-rate effects Radiother. Oncol. 37 131-5
158. Vesselov L, Whittington W and Lilge L 2005 Design and performance of thin cylindrical diffusers created in Ge-doped multimode optical fibers Appl. Opt. 44 2754-8
159. Wang I, Andersson-Engels S, Nilsson G E, Wardell K and Svanberg K 1997 Superficial blood flow following photodynamic therapy of malignant non-melanoma skin tumours measured by laser Doppler perfusion imaging Br. J. Dermatol. 136 184-9
160. Wang L H, Jacques S L and Zheng L Q 1995 MCML-Monte-Carlo modeling of light transport in multilayered tissues Comput. Methods Programs Biomed. 47 131-46
161. Wang K K H, Mitra S and Foster T H 2007 A comprehensive mathematical model of microscopic dose deposition in photodynamic therapy Med. Phys. 34 282-93
162. Weersink R A, Bogaards A, Gertner M, Davidson S R H, Zhang K, Netchev G, Trachtenberg J and Wilson B C 2005 Techniques for delivery and monitoring of TOOKAD (WST09)-mediated photodynamic therapy of the prostate: clinical experience and practicalities J. Photochem. Photobiol. 79 211-22
163. Weersink R A, Hayward J E, Diamond K R and Patterson M S 1997 Accuracy of noninvasive in vivo measurements of photosensitizer uptake based on a diffusion model of reflectance spectroscopy Photochem. Photobiol. 66 326-35
164. Weishaupt K R, Gomer C J and Dougherty T J 1976 Identification of singlet oxygen as cytotoxic agent in photo-inactivation of a murine tumor Cancer Res. 36 2326-9
165. Weissleder R, Tung C H, Mahmood U and Bogdanov A 1999 In vivo imaging of tumors with protease-activated near-infrared fluorescent probes Nat. Biotechnol. 17 375-8
166. Wilson M 2004 Lethal photosensitisation of oral bacteria and its potential application in the photodynamic therapy of oral infections Photochem. Photobiol. Sci. 3 412-8
167. Wilson B C 2006 Photonic and non photonic-based nanoparticles for cancer imaging and therapeutics Photon Based Nanoscience and Nanobiotechnology ed J Dubowski and S Tanev (Netherlands: Springer) pp 121-51
168. Wilson B C and Patterson M S 1986 The physics of photodynamic therapy Phys. Med. Biol. 31 327-60
169. Wilson B C, Patterson M S and Lilge L 1997 Implicit and explicit dosimetry in photodynamic therapy: a new paradigm Lasers Med. Sci. 12 182-99
170. Wilson B C and Vanlier J E 1989 Radiolabeled photosensitizers for tumor imaging and photodynamic therapy J. Photochem. Photobiol. 3 459-63
171. Woodhams J H, Kunz L, Bown S G and MacRobert A J 2004 Correlation of real-time haemoglobin oxygen saturation monitoring during photodynamic therapy with microvascular effects and tissue necrosis in normal rat liver Br. J. Cancer 91 788-94
172. Xu M and Alfano R R 2005 Fractal mechanisms of light scattering in biological tissue and cells Opt. Lett. 30 3051-3
173. Xu H P and Patterson M S 2006 Application of the modified spherical harmonics method to some problems in biomedical optics Phys. Med. Biol. 51 N247-51
174. Yamamoto J et al 2006 Monitoring of singlet oxygen is useful for predicting the photodynamic effects in the treatment for experimental glioma Clin. Cancer Res. 12 7132-9
175. Yu C, Canteenwala T, El Khouly M E, Araki Y, Pritzker K, Ito O, Wilson B C and Chiang L Y 2005a Efficiency of singlet oxygen production from
176. Yu G Q, Durduran T, Zhou C, Wang H W, Putt M E, Saunders H M, Sehgal C M, Glatstein E, Yodh A G and Busch T M 2005b Noninvasive monitoring of murine tumor blood flow during and after photodynamic therapy provides early assessment of therapeutic efficacy Clin. Cancer Res. 11 3543-52
177. Yu G, Durduran T, Zhou C, Zhu T C, Finlay J C, Busch T M, Malkowicz S B, Hahn S M and Yodh A G 2006 Real-time in situ monitoring of human prostate photodynamic therapy with diffuse light Photochem. Photobiol. 82 1279-84
178. Yuan J, Mahama-Relue P A, Fournier R L and Hampton J A 1997 Predictions of mathematical models of tissue oxygenation and generation of singlet oxygen during photodynamic therapy Radiat. Res. 148 386-94
179. Zelickson B, Counters J, Coles C and Selim M 2005 Light patch: preliminary report of a novel form of blue light delivery for the treatment of actinic keratosis Dermatol. Surg. 31 375-8
180. Zeng H S, Korbelik M, Mclean D I, MacAulay C and Lui H 2002 Monitoring photoproduct formation and photobleaching by fluorescence spectroscopy has the potential to improve PDT dosimetry with a verteporfin-like photosensitizer Photochem. Photobiol. 75 398-405
181. Zheng G, Chen J, Stefflova K, Jarvi M, Li H and Wilson B C 2007 Photodynamic molecular beacon as an activatable photosensitizer based on protease-controlled singlet oxygen quenching and activation Proc. Natl Acad. Sci. USA 104 8989-94
182. Zhou X D, Pogue B W, Chen B, Demidenko E, Joshi R, Hoopes J and Hasan T 2006 Pretreatment photosensitizer dosimetry reduces variation in tumor response Int. J. Radiat. Oncol. Biol. Phys. 64 1211-20
183. Zhu T C, Finlay J C and Hahn S M 2005 Determination of the distribution of light, optical properties, drug concentration, and tissue oxygenation in-vivo in human prostate during motexafin lutetium-mediated photodynamic therapy J. Photochem. Photobiol. 79 231-41